American Academy of Neurology 55th Annual Meeting
Honolulu, March 29th - April 5th, 2003

Ataxia/Olivopontocerebellar atrophy

• SiRNA In Cell Models of DYT1 Dystonia, Polyglutamine disease
• Tremor-Ataxia Syndrome From Fragile X Premutation

Dystonia

• SiRNA In Cell Models of DYT1 Dystonia, Polyglutamine disease

Essential tremor - See Tremor

• Treatment of Essential Tremor

Huntington's disease

• SiRNA In Cell Models of DYT1 Dystonia, Polyglutamine disease

Multiple system atrophy

• Tremor-Ataxia Syndrome From Fragile X Premutation

Parkinson's disease

• Continued Efficacy of Injectable Apomorphine
• Long-Duration Improvement from STN DBS
• Protein Processing in PD
• West Indies PSP Toxin is a Complex I Inhibitor
• Epidemiology of Parkinson's Disease
• Sertraline for PD Depression
• PD Instability Test Often Performed Incorrectly
• APOE-4 Increases Risk, Lowers Age of Onset of PD

Progressive supranuclear palsy

• West Indies PSP Toxin is a Complex I Inhibitor

Restless legs syndrome

• RLS Quality of Life Reduction is Significant
• Dopamine Agonists for RLS

Tardive dyskinesia/Dystonia

• Reduced Risk of Tardive Dyskinesia with Atypical Antipsychotics

Tics/Tourette's syndrome

• OCD and ADHD, Not Tics, Predict Quality of Life in Tourette Syndrome

Tremor

• Tremor-Ataxia Syndrome From Fragile X Premutation
• Treatment of Essential Tremor

Meeting Reports Menu